PHEMI Announces A New Board Chair And Appoints Leading Health Sciences Expert To Board

I am delighted to be joining PHEMI’s Board of Directors. We recognize the potential big data holds for a growing number of companies operating in both the life sciences industry and other verticals. PHEMI, a Vancouver-based technology company, demonstrates leadership and innovation by offering big data solutions with built-in privacy, governance, and enterprise-grade management. Quark Venture and GF Securities, through the Global Health Sciences Fund, invested in PHEMI last June 2017. See PHEMI’s release below.

Karimah Es Sabar
CEO and Partner, Quark Venture
Director, Global Health Sciences Fund

PHEMI Announces A New Board Chair And Appoints Leading Health Sciences Expert To Board

VANCOUVER, British Columbia – Feb. 22, 2018 — Rick Makos, President and CEO of PHEMI, the company delivering big data solutions with built-in privacy, governance, and enterprise-grade management, today announced Mike Satterfield as the new PHEMI Board Chair, and welcomed Karimah Es Sabar, President and CEO, Quark Venture Inc, onto the company’s board.

Mike Satterfield, a co-founder, advisor and former partner with Yaletown Partners, brings almost 40 years of technology entrepreneurship, executive management and governance experience to PHEMI. Satterfield succeeds PHEMI co-founder John Seminerio as Chair. Seminerio will continue to support PHEMI’s growth as an advisor to the Company.

Satterfield led and continues to manage Yaletown’s investments in PHEMI, Elastic Path, Tasktop and Tutela and led realized investments in Indicee and Partnerpedia. Previously, he was co-founder and CEO of Simba Technologies, a Vancouver-based data connectivity and analytics software company acquired by CRM vendor Pivotal Corporation and recently re-acquired by Magnitude Software.

“Mike’s extensive expertise and deep knowledge of the software industry, the tech marketplace and how to build and expand distribution networks is a huge asset and will be extremely valuable as we move PHEMI forward,” said Rick Makos, President and CEO, PHEMI. “I also want to thank John Seminerio for his guidance and leadership as past Board chair and express how pleased we are to continue to have him involved in an advisory capacity.”

As the newest appointment to the PHEMI Board, Karimah Es Sabar brings a depth of experience in Health Sciences and has a successful career spanning multi-national pharmaceutical/biotechnology companies, start-up companies, not-for-profit organizations and venture investment firm. She has provided leadership in marketing, business development, strategic alliances, global collaborations, public private partnerships, developing and executing innovation and translation strategies in the life science sector, building innovation ecosystems, entrepreneurship in startups, and in biotech investment.

n addition to her role as President and CEO Quark Venture Inc., a venture investment firm focused on life sciences, she is Director of one of the largest global health sciences (GHS) fund, a partnership with GF Securities, a leading investment bank in China. The GHS fund announced an investment in PHEMI last June.

“We are so fortunate to have access to Karimah Es Sabar’s depth of knowledge and experience in a sector that holds huge potential. Her deep connections across the Health sector from the Provincial and Federal Governments and research institutions to biotech start ups and big pharmaceutical companies, will open doors, new markets for our enterprise-grade big data solutions,” said Rick Makos, President and CEO, PHEMI.

“PHEMI is at the frontier of emerging and converging technologies addressing the demand for solutions that meet government and privacy requirements. Big data has the potential to reshape how we do business and deliver health. It will be the new health care currency and a critical business asset because it will generate deep insights into populations, better treatments, diagnotics and precision medicine,” said Karimah Es Sabar. “I am delighted to be part of PHEMI’s board and am excited about where it will go.”


Share data responsibly.Whether you’re drowning in data or thirsting for insights, PHEMI helps organizations make better decisions faster by mining complex data and unlocking new and actionable insights.

Our flagship product, PHEMI Central, is a new class of data management software that brings enterprise-grade privacy, security and governance to sensitive data, removing a critical roadblock standing in the way of enterprises that aim to become data-driven. Named Gartner Cool Vendor and Deloitte Technology Fast 50, PHEMI is the first vendor to bring real-time policy-based privacy enforcement and data governance to big data.